Regulatory and other responses to the pharmaceutical opioid problem

Thomas Polasek; Melody Caramins; Graeme Suthers

doi:10.5694/mja2.50297

Regulatory and other responses to the pharmaceutical opioid problem

Thomas Polasek
, Melody Caramins
, Graeme Suthers

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Abstract

To the Editor: We read with interest the article regarding Australia's approach to managing the challenges of pharmaceutical opioid utilisation.1 The various regulatory, service delivery and educational activities described would appear to provide a comprehensive response to this problem. However, we were surprised to note the absence of any reference to the potential of pharmacogenomics in identifying patients at increased risk of opioid toxicity.

Original language	English
Pages (from-to)	237-237.e1
Number of pages	1
Journal	Medical Journal of Australia
Volume	211
Issue number	5
DOIs	https://doi.org/10.5694/mja2.50297
Publication status	Published - Sept 2019
Externally published	Yes

Keywords

Analgesics, opioid
Codeine
Pharmacogenomics

Access to Document

10.5694/mja2.50297Licence: In Copyright

Cite this

@article{a1968bcb33434b72a3c5dafa54be8920,

title = "Regulatory and other responses to the pharmaceutical opioid problem",

abstract = "To the Editor: We read with interest the article regarding Australia's approach to managing the challenges of pharmaceutical opioid utilisation.1 The various regulatory, service delivery and educational activities described would appear to provide a comprehensive response to this problem. However, we were surprised to note the absence of any reference to the potential of pharmacogenomics in identifying patients at increased risk of opioid toxicity.",

keywords = "Analgesics, opioid, Codeine, Pharmacogenomics",

author = "Thomas Polasek and Melody Caramins and Graeme Suthers",

year = "2019",

month = sep,

doi = "10.5694/mja2.50297",

language = "English",

volume = "211",

pages = "237--237.e1",

journal = "Medical Journal of Australia",

issn = "0025-729X",

publisher = "John Wiley \& Sons, Inc",

number = "5",

}

TY - JOUR

T1 - Regulatory and other responses to the pharmaceutical opioid problem

AU - Polasek, Thomas

AU - Caramins, Melody

AU - Suthers, Graeme

PY - 2019/9

Y1 - 2019/9

N2 - To the Editor: We read with interest the article regarding Australia's approach to managing the challenges of pharmaceutical opioid utilisation.1 The various regulatory, service delivery and educational activities described would appear to provide a comprehensive response to this problem. However, we were surprised to note the absence of any reference to the potential of pharmacogenomics in identifying patients at increased risk of opioid toxicity.

AB - To the Editor: We read with interest the article regarding Australia's approach to managing the challenges of pharmaceutical opioid utilisation.1 The various regulatory, service delivery and educational activities described would appear to provide a comprehensive response to this problem. However, we were surprised to note the absence of any reference to the potential of pharmacogenomics in identifying patients at increased risk of opioid toxicity.

KW - Analgesics, opioid

KW - Codeine

KW - Pharmacogenomics

UR - https://www.scopus.com/pages/publications/85070710496

U2 - 10.5694/mja2.50297

DO - 10.5694/mja2.50297

M3 - Letter

C2 - 31389024

AN - SCOPUS:85070710496

SN - 0025-729X

VL - 211

SP - 237-237.e1

JO - Medical Journal of Australia

JF - Medical Journal of Australia

IS - 5

ER -

Regulatory and other responses to the pharmaceutical opioid problem

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this